Abstract
In recent years, there has been an increasing interest in developing dose finding methods incorporating both efficacy and toxicity outcomes. It is reasonable to assume that efficacy and toxicity are associated; therefore, we need to model their stochastic dependence. Copula functions are very useful tools to model different kinds of dependence with arbitrary marginal distributions. We consider a binary efficacy-toxicity response with logit marginal distributions. Since the dose which maximizes the probability of efficacy without toxicity (P-optimal dose) changes depending on different copula functions, we propose a criterion which is useful for choosing between the rival copula models but also protects patients against doses that are far away from the P-optimal dose. The performance of this compromise criterion (called PKL) is illustrated for different choices of the parameter values.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aletti, G., May, C., Tommasi, C.: KL-optimum designs: theoretical properties and practical computation. Stat. Comput. (2014). doi:10.1007/s11222-014-9515-8
Denman, N.G., McGree, J.M., Eccleston, J.A., Duffull, S.B.: Design of experiments for bivariate binary responses modelled by copula functions. Comput. Stat. Data Anal. 55, 1509–1520 (2011)
Dragalin, V., Fedorov, V., Wu, Y.: A two-stage design for dose-finding that accounts for both efficacy and safety. Stat. Med. 27, 5156–5176 (2008)
Fedorov, V., Hackl, P.: Model-Oriented Design of Experiments. Springer, New York (1997)
Gao, L., Rosenberger, W.F.: Adaptive Bayesian design with penalty based on toxicity-efficacy response. In: Ucinski, D., Atkinson, A.C., Patan, M. (eds.) mODa 10 – Advances in Model-Oriented Design and Analysis, pp. 91–98. Springer International Publishing, Heidelberg (2013)
López-Fidalgo, L.J., Tommasi, C., Trandafir, P.C.: An optimal experimental design criterion for discriminating between non-normal models. J. R. Stat. Soc. B 69 (2), 231–242 (2007)
McGree, J.M., Eccleston, J.A.: Probability-based optimal design. Aust. N. Z. J. Stat. 50, 13–28 (2008)
Nelsen, R.B.: An Introduction to Copulas. Springer, New York (2006)
Perrone, E., Müller, W.G.: Optimal designs for copula models. In: IFAS Research Paper Series 2014–66, Department for Applied Statistics, Johannes Kepler University Linz.http://www.jku.at/ifas/content/e108280/e146255/e241527/ifas_rp66.pdf. Cited May 2014
Thall, P.F., Cook, J.D.: Dose-finding based on efficacy-toxicity trade-offs. Biometrics 60, 684–693 (2004)
Tommasi, C.: Optimal designs for both model discrimination and parameter estimation. J. Stat. Plan. Inference 139, 4123–4132 (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this paper
Cite this paper
Deldossi, L., Osmetti, S.A., Tommasi, C. (2016). PKL-Optimality Criterion in Copula Models for Efficacy-Toxicity Response. In: Kunert, J., Müller, C., Atkinson, A. (eds) mODa 11 - Advances in Model-Oriented Design and Analysis. Contributions to Statistics. Springer, Cham. https://doi.org/10.1007/978-3-319-31266-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-31266-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31264-4
Online ISBN: 978-3-319-31266-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)